New Year’s Holiday Sale: ends december 31st
A 2025 study published in The American Journal of Sports Medicine tracked 129 Major League Baseball pitchers over three seasons following ulnar collateral ligament reconstruction to answer a question that matters far more than whether an athlete can return to throwing. Can they return to performing at the level they were at before surgery? Researchers Mastroianni and colleagues examined not just return-to-play rates, which have been well documented in previous research, but return-to-performance across multiple advanced metrics that actually determine whether a pitcher is effective. What they found should fundamentally change how we think about rehabilitation timelines, how we structure return-to-throw protocols, and what expectations we set with athletes and organizations about what UCL surgery can and cannot restore.
Only 1.6 percent of pitchers returned to play within one year. By year three, 82 percent had returned to the mound, with an average timeline of 584 days post-surgery. Those numbers sound encouraging until you look at return-to-performance. Just 3.9 percent met full-performance criteria at year one. By year three, that number increased to 28.1 percent. Full performance was defined as recovery across five key metrics, expected Fielding Independent Pitching, Wins Above Replacement, overall velocity, fastball velocity, and spin rate. The researchers chose these metrics because they capture different dimensions of pitching effectiveness, stuff quality, command, workload capacity, and raw output. When they examined individual metric recovery rates at three years, the picture became even more sobering. Fastball velocity returned in 80 percent of pitchers, Stuff+ in 78 percent, Location+ in 89 percent, but fWAR, which reflects actual value and playing time, returned in only 48 percent. Most striking of all, only 19.3 percent of pitchers met four out of five full-performance metrics. Near-complete recovery is not just rare, it's the exception.
The researchers analyzed pitchers who underwent UCL reconstruction between 2010 and 2020, tracking their performance metrics across three post-operative seasons and comparing them to their pre-injury baseline. They defined return-to-play as appearing in at least one Major League game and defined return-to-performance as achieving statistical metrics within one standard deviation of the pitcher's pre-injury average. The use of advanced metrics like Stuff+, Location+, and expected FIP allowed them to separate physical capacity from actual effectiveness, which is critical because an athlete can have their velocity back but still pitch poorly if their command, pitch quality, or durability hasn't recovered.
The timeline for return-to-play was consistent with what previous research has shown. Very few pitchers make it back within 12 months, the bulk return between 18 and 24 months, and by three years, the vast majority who are going to return have done so. But the timeline for return-to-performance lagged significantly behind. At year one, when a small percentage of pitchers had returned to competition, almost none were performing at their pre-injury level. By year two, return-to-performance rates improved but still remained well below return-to-play rates. By year three, the gap persisted, 82 percent had returned to play but only 28.1 percent had returned to full performance across all five metrics.
Location+, which measures command and the ability to locate pitches where intended, had the highest recovery rate at 89 percent by year three. This suggests that motor control and the ability to repeat mechanics returns more reliably than raw output like velocity or the ability to sustain high workloads. Fastball velocity returned in 80 percent, which is encouraging on the surface but still means one in five pitchers never fully regain the speed they had before surgery. fWAR, which incorporates both performance and playing time, returned in less than half of pitchers, indicating that even when physical metrics recover, many athletes struggle to maintain the workload or consistency needed to accumulate value over a full season.
Starting pitchers, athletes with high pre-operative velocity, and older pitchers all had significantly lower odds of regaining full performance. The demands on starting pitchers, longer outings, higher total pitch counts per appearance, more frequent use of secondary pitches, may make it harder for them to fully recover compared to relievers who can maximize effort over shorter bursts. High-velocity pitchers might be operating closer to their biological limits, which means that any loss of arm strength, coordination, or tissue quality post-surgery manifests as a more noticeable decline. Older athletes face the compounding challenge of natural age-related decline on top of surgical recovery, which creates a steeper hill to climb.
The researchers didn't just look at whether pitchers hit their benchmarks, they examined what predicted success. Higher pre-operative velocity was paradoxically associated with worse outcomes, which might seem counterintuitive until you consider that velocity is a marker of how much stress the arm was handling before surgery. Athletes who were throwing harder were likely experiencing greater tissue loads, and recovering that capacity after reconstruction may be more difficult than recovering moderate velocity. Age and role, starter versus reliever, also emerged as significant predictors, reinforcing the idea that context matters enormously when projecting post-surgical outcomes.
To be honest, this reminds me of every conversation I've had with athletes or parents who hear "medically cleared" and assume the pitcher is back. Cleared to throw is not the same as ready to perform. Cleared means the ligament has healed enough to tolerate stress without catastrophic failure. Ready means the athlete has regained strength, coordination, endurance, and confidence to execute at their pre-surgery level. This study makes it clear those two states are separated by months or years, not weeks.
The fact that command recovers faster than velocity or workload tells us something important about what UCL surgery actually affects. The ligament is a passive restraint against valgus stress. Reconstructing it restores structural integrity, but doesn't directly restore neuromuscular coordination, muscle strength, or tissue resilience. Command, the ability to hit spots, is about motor control and timing more than raw force. That's why it comes back reliably. Velocity and durability require restored strength throughout the kinetic chain, confidence to let the arm move freely, and conditioned tissues that can handle cumulative stress.
Research on fastball quality reinforces this. A study of 91 pitchers found that velocity and spin returned in year one, but fastball quality and usage declined sharply. Pitchers threw as hard and spun the ball as much as before surgery, but effectiveness dropped significantly. Quality didn't normalize until year two. Physical capacity returns before the ability to execute effectively under game conditions. Another study of 43 pitchers found 58 percent showed performance drops in their first post-operative season, with full recovery taking until season two. Off-speed spin rate declined in year one and recovered by year two. Secondary pitches require more refined control and take longer to recover than physical capacity alone.
Revision surgery outcomes are even more sobering. Analysis of 191 pitchers showed only 72 percent returned to play at any level, just 59 percent to their previous level. Average return took 556 days, often costing two full seasons. Revision rates increased 2.22 times compared to the previous decade, raising questions about whether athletes are being pushed back too aggressively or whether biological limits are being reached.
Research on UCL injury risk shows workload management, particularly early-season and early-career, plays significant roles. If mismanagement contributed to the initial injury, returning to the same patterns without addressing them sets up reinjury. A review of interval throwing programs found most have poor methodological quality and don't account for individual differences. Research showing pitchers can't accurately gauge their own effort compounds this, athletes consistently underestimate intensity, so self-reported effort can't guide progression. Objective measures are essential but often missing.
If you're working with pitchers post-UCL surgery, recalibrate expectations. Returning to dominance takes years, not months. By year three, only 28 percent achieved full performance across all five metrics. The narrative of "Tommy John surgery gives you a bionic arm" needs to die. Surgery restores structural integrity but doesn't make athletes better, and often leaves them operating at diminished capacity even after recovery.
Build rehabilitation around multi-phase return-to-value frameworks, not binary cleared-or-not protocols. Clearance should be the beginning of structured progression through phases targeting different performance dimensions. Early phases focus on motor control and command. Middle phases layer velocity and movement quality. Later phases address workload tolerance, where fWAR recovery lags most.
Gradually layer training variables rather than ramping everything simultaneously. Command first, then velocity incrementally while monitoring whether command degrades. Once the athlete maintains command at full velocity, increase workload through pitches per session, frequency, then competitive intensity. This sequencing matches natural recovery curves and reduces pushing too hard too soon.
Match progression to role and pre-surgery profile. Starting pitchers need longer timelines than relievers to rebuild endurance and repertoire depth. High-velocity pitchers need attention to whether they regain top-end speed or settle into a lower band, requiring pitch mix adjustments. Older athletes must account for natural decline on top of surgical recovery.
Use objective measures to guide progression. Track velocity, monitor workload, assess command through strike percentage and location metrics, and use biomechanical evaluations if available. When measures plateau or regress, adjust the program by backing off workload, focusing on lagging qualities, or addressing mechanical issues.
Build in patience and accept setbacks as normal. Average 584 days to return to play, and full performance often takes another year beyond that, means two to three years from surgery to peak post-operative performance. Compressing that timeline almost always backfires. Setbacks are expected, the key is responding appropriately rather than panicking or rushing forward.
The finding that only 28.1 percent of Major League Baseball pitchers achieve full performance across five key metrics by three years post-UCL surgery challenges the optimistic narrative that surrounds Tommy John surgery in popular culture. Return-to-play rates are high, 82 percent by year three, but returning to the mound is very different from returning to effectiveness. Command recovers most reliably, with 89 percent of pitchers regaining their ability to locate pitches, but velocity, workload capacity, and overall value as measured by fWAR lag significantly. Starting pitchers, high pre-operative velocity athletes, and older pitchers face the steepest odds of full recovery.
Supporting research confirms that physical capacity returns before performance quality. Velocity and spin rate normalize in year one, but fastball effectiveness doesn't catch up until year two. Performance declines are common in the first post-operative season, even when the athlete has been medically cleared. Revision surgery outcomes are significantly worse than primary surgery, with only 59 percent of pitchers returning to their previous level of competition. Workload mismanagement contributes to injury risk, and many publicly available rehabilitation programs lack the methodological rigor needed to guide athletes through a safe, effective return.
The application for coaches, rehab specialists, and athletes is clear. Medical clearance doesn't mean performance ready. Multi-phase return-to-value frameworks that gradually layer command, velocity, movement quality, and workload are needed to match the natural recovery curve. Objective measures must guide progression because athletes can't accurately self-assess effort or readiness. Starting pitchers need longer timelines than relievers, high-velocity pitchers may not regain their peak speed, and older athletes face compounding challenges. Expectations need recalibration, returning to dominance takes years, not months, and patience isn't optional if the goal is long-term career preservation rather than short-term availability. The surgery restores structure, but rebuilding performance is a multi-year process that requires systematic progression, careful monitoring, and realistic expectations about what's achievable.
.png)
.png)
.png)
.png)
